RNA-guided gene activation by CRISPR-Cas9–based transcription factorsPablo Pérez‐Piñera, Charles A. Gersbach, D. Dewran Koçak et al.|Nature Methods|2013Cited by 1.3k
Synergistic and tunable human gene activation by combinations of synthetic transcription factorsPablo Pérez‐Piñera, Charles A. Gersbach, Katherine A. Glass et al.|Nature Methods|2013Cited by 241
Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy PatientsDavid G. Ousterout, Charles A. Gersbach, Pablo Pérez‐Piñera et al.|Molecular Therapy|2013Cited by 176
Advances in targeted genome editingPablo Pérez‐Piñera, Charles A. Gersbach, David G. Ousterout|Current Opinion in Chemical Biology|2012Cited by 158
Correction of Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients Through Genomic Excision of Exon 51 by Zinc Finger NucleasesDavid G. Ousterout, Charles A. Gersbach, Ami M. Kabadi et al.|Molecular Therapy|2014Cited by 111